Thursday, December 31, 2009

Biodel Submits Viaject New Diabetes Drug For FDA Approval - Visit Bulgaria


Visit Bulgaria

Biodel Submits Viaject New Diabetes Drug For FDA Approval
Visit Bulgaria
... losses earlier this month narrowing down to $10.5-million. Biodel's shares gaining 1.7% to $4.20, in after-hours trading, had fallen 14% during the year.

and more »

No comments:

Post a Comment